Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
2(22%)
Results Posted
20%(1 trials)

Phase Distribution

Ph not_applicable
7
78%
Ph phase_3
1
11%
Ph phase_4
1
11%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution9 total trials
Phase 3Large-scale testing
1(11.1%)
Phase 4Post-market surveillance
1(11.1%)
N/ANon-phased studies
7(77.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

9

all time

Status Distribution
Active(2)
Completed(5)
Other(2)

Detailed Status

Completed5
Recruiting2
unknown2

Development Timeline

Analytics

Development Status

Total Trials
9
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (11.1%)
Phase 41 (11.1%)
N/A7 (77.8%)

Trials by Status

recruiting222%
completed556%
unknown222%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
PROCEDURE
Total Trials
9